Clinical Trial Update: A Study of the Effectiveness and Safety of SP2086 to Treat Type 2 Diabetes [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating SP2086 for Type 2 Diabetes has completed, reporting on its effectiveness and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SP2086

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED